Why is IVIg given in thrombocytopenia?
•
4 min read
The annual incidence of immune thrombocytopenia (ITP) in adults is estimated to be 1 to 6 cases per 100,000 people. A primary clinical question is, **why is IVIg given in thrombocytopenia?** This therapy is essential for rapidly boosting platelet counts in critical situations.
